GlassScriptPhysician profile
Cassandra L Ditchfield
NPI 1598274532
$9,814.11
in general payments reported to CMS, 2019-2025
78 companies · $3,272 in 2025
The $3,272 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,851 · 2023: $2,367 · 2024: $2,324 · 2025: $3,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,601 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,601.11 |
| Education | $361.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $717.22 | 2022-2025 | |
| Janssen Biotech, INC. | $639.72 | 2022-2025 | Tecvayli, Darzalex, Erleada |
| Merck Sharp & Dohme LLC | $582.03 | 2022-2025 | Keytruda, Lynparza, Lenvima |
| Astrazeneca Pharmaceuticals LP | $549.25 | 2022-2025 | Lynparza, Enhertu, Imfinzi |
| Daiichi Sankyo INC. | $451.67 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Pfizer INC. | $442.67 | 2022-2025 | |
| Eisai INC. | $407.95 | 2022-2025 | |
| Incyte Corporation | $395.32 | 2022-2025 | Jakafi, Niktimvo, Monjuvi |
| Aveo Pharmaceuticals, INC. | $333.90 | 2022-2025 | |
| Genentech USA, INC. | $278.26 | 2022-2025 | Venclexta, Tecentriq, Avastin |
| Genzyme Corporation | $265.31 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $263.13 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $252.59 | 2022-2025 | Opdivo, Eliquis, Camzyos |
| Glaxosmithkline, LLC. | $227.03 | 2022-2025 | Ojjaara, Blenrep, Zejula |
| Exelixis INC. | $226.79 | 2022-2025 | Cabometyx |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $225.81 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $190.28 | 2022-2025 | Ninlaro, Alunbrig |
| Puma Biotechnology, INC. | $187.40 | 2022-2025 | |
| Array Biopharma INC | $157.60 | 2022-2025 | Braftovi, Lorbrena, Mektovi |
| Gilead Sciences, INC. | $157.20 | 2022-2025 | Trodelvy |
| Acrotech Biopharma INC. | $128.33 | 2022-2025 | Beleodaq |
| Sobi, INC | $127.23 | 2022-2025 | |
| Karyopharm Therapeutics INC. | $124.57 | 2022-2025 | Xpovio |
| Celgene Corporation | $124.18 | 2022-2023 | Reblozyl, Opdualag, Pomalyst |
| Alexion Pharmaceuticals, INC. | $118.20 | 2022-2024 | Ultomiris |
| Servier Pharmaceuticals LLC | $116.91 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $112.17 | 2022-2025 | Onivyde, Somatuline Depot |
| Astellas Pharma US INC | $111.93 | 2023-2025 | Vyloy, Padcev, Xtandi |
| Beigene USA, INC. | $106.71 | 2022-2025 | Brukinsa |
| Sanofi-Aventis U.S. LLC | $99.00 | 2023 | |
| Jazz Pharmaceuticals INC. | $94.48 | 2022-2025 | |
| Adc Therapeutics America, INC. | $78.70 | 2022-2025 | |
| Beone Medicines USA, INC. | $78.53 | 2025 | Brukinsa, Tevimbra |
| Seagen INC. | $76.68 | 2022-2023 | Padcev, Adcetris |
| Regeneron Healthcare Solutions, INC. | $68.27 | 2023-2025 | Libtayo, Lynozyfic |
| Taiho Oncology, INC. | $67.84 | 2022-2025 | |
| Deciphera Pharmaceuticals INC. | $63.23 | 2022-2025 | |
| Amgen INC. | $62.33 | 2022-2023 | Lumakras, Xgeva, Vectibix |
| Springworks Therapeutics, INC. | $60.40 | 2024-2025 | Ogsiveo |
| Abbvie INC. | $58.40 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.40 | 2022-2023 | Gilotrif |
| Tempus Ai, INC | $49.89 | 2025 | Xt Cdx |
| Novocure INC. | $46.91 | 2022 | |
| Pharmaessentia USA Corporation | $45.57 | 2025 | Besremi |
| G1 Therapeutics, INC. | $39.21 | 2022-2023 | Cosela |
| Coherus Oncology, INC. | $38.65 | 2022-2024 | |
| Cycle Pharmaceuticals INC | $35.92 | 2025 | Phyrago |
| Pharmacosmos Therapeutics INC. | $35.42 | 2024-2025 | Cosela, Monoferric |
| Immunocore Limited | $33.82 | 2025 | Kimmtrak |
| Azurity Pharmaceuticals, INC. | $33.77 | 2024-2025 | Vivimusta, Danziten |
| Avyxa Pharma, LLC | $33.59 | 2024 | |
| Biocon Biologics INC | $31.07 | 2025 | Ogivri |
| Tersera Therapeutics LLC | $30.79 | 2022-2025 | Xermelo |
| Genmab U.S., INC. | $29.55 | 2023 | Tivdak |
| Epizyme, INC. | $29.01 | 2022 | |
| Fresenius Kabi USA, LLC | $26.28 | 2024 | Stimufend |
| Geron Corporation | $25.89 | 2025 | Rytelo |
| Stemline Therapeutics INC. | $24.85 | 2023 | Orserdu |
| Accord Healthcare, INC. | $22.56 | 2025 | |
| Adaptive Biotechnologies Corporation | $19.88 | 2025 | Clonoseq |
| Kyowa Kirin, INC. | $19.84 | 2025 | |
| Myriad Genetic Laboratories, INC. | $19.61 | 2024 | Precisetumor |
| Emd Serono, INC. | $19.30 | 2023 | Bavencio |
| Tg Therapeutics, INC. | $18.90 | 2022 | |
| Celltrion USA INC. | $18.57 | 2024 | Vegzelma |
| Caris Mpi, INC. | $18.50 | 2025 | Mi Cancer Seek |
| Telix Pharmaceuticals | $17.87 | 2025 | Illuccix |
| Alnylam Pharmaceuticals INC. | $17.55 | 2025 | Givlaari |
| Sun Pharmaceutical Industries INC. | $17.29 | 2022 | |
| Apellis Pharmaceuticals, INC. | $17.11 | 2025 | Empaveli |
| Macrogenics, INC. | $16.78 | 2022 | |
| Inari Medical, INC. | $16.32 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recordati_rare_diseases_inc. | $15.73 | 2025 | Enjaymo |
| Spectrum Pharmaceuticals INC. | $15.58 | 2023 | Rolvedon |
| Rigel Pharmaceuticals, INC. | $14.40 | 2025 | Rezlidhia, Tavalisse, Gavreto |
| Mirati Therapeutics, INC. | $13.67 | 2024 | Krazati |
| Nestle Healthcare Nutrition INC. | $12.48 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $12.36 | 2022 |
Drugs and devices associated with these payments
Keytruda $473Lenvima $405Fotivda $303Jakafi $288Enhertu $273Lynparza $270Kisqali $218Jevtana $211Nubeqa $207Xofigo $207Cabometyx $193Pluvicto $192Tecvayli $159Darzalex $152Venclexta $152Verzenio $150Jaypirca $150Adcetris $146Elrexfio $139Ojjaara $131Brukinsa $127Braftovi $123Lutathera $112Padcev $112Tecentriq $111Erleada $110Lorbrena $103Imbruvica $98.11Xtandi $97.80Xpovio $97.01Gavreto $93.45Retevmo $93.08Rybrevant $89.41Ultomiris $89.33Injectafer $88.12Imfinzi $87.75Beleodaq $85.19Mektovi $83.31Bosulif $83.00Opdivo $82.65Rozlytrek $79.05Alecensa $79.05Avastin $79.05Reblozyl $77.99Sarclisa $74.02Akeega $71.24Ibrance $70.25Ninlaro $69.57Tukysa $69.21Calquence $67.57Inlyta $67.38Talvey $64.57Paxlovid $61.35Ogsiveo $60.40Niktimvo $56.16Onivyde $55.17Tagrisso $55.12Nerlynx $52.46Tibsovo $51.70Piqray $51.36Inqovi $51.11Lonsurf $51.11Libtayo $50.30Xt Cdx $49.89Trodelvy $49.56Bavencio $49.29Fabhalta $49.12Comirnaty $48.44Blenrep $47.21Besremi $45.57Zejula $41.81Jemperli $41.81Datroway $41.75Talzenna $38.68Orgovyx $36.19Phyrago $35.92Somatuline Depot $35.76Illuccix $35.74Eliquis $35.42Cosela $34.74Vyloy $34.53Zynlonta $34.41Kimmtrak $33.82Docivyx $33.59Scemblix $32.19Balversa $31.93Ogivri $31.07Tabrecta $30.85Emrelis $30.26Tivdak $29.55Stivarga $29.42Vitrakvi $29.42Stimufend $26.28Rytelo $25.89Orserdu $24.85Voranigo $24.79Besponsa $24.17Tevimbra $23.58Udenyca $23.17Camcevi $22.56
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Ditchfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.